Invest now
Ajanta Pharma Balance Sheet Annual
BSE: - | NSE: - | ISIN: - | Sector: -3,431.40 -21.55 (-0.62%)Updated : 16 Jul 2026
Research on
| Fiscal Period | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Period End Date | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
| Total Liabilities Shareholders' Equity | 6,154.84 | 5,014.95 | 4,638.39 | 4,679.02 |
| Accumulated Depreciation Total | -1,129.33 | -1,002.48 | -881.04 | -762.25 |
| Other Liabilities Total | 54.64 | 83.32 | 43.76 | 27.83 |
| Common Stock Total | 25.07 | 25.07 | 25.27 | 25.27 |
| Other Equity Total | 41.37 | 12.29 | 10.44 | 9.63 |
| Other Current Assets Total | 1.20 | 14.45 | 22.61 | 1.07 |
| Prepaid Expenses | 32.55 | 24.58 | 25.92 | 16.44 |
| Total Assets | 6,154.84 | 5,014.95 | 4,638.39 | 4,679.02 |
| Current Portof LT Debt/ Capital Leases | 13.86 | 12.70 | 11.76 | 9.43 |
| Additional Paid- In Capital | 7.16 | 3.66 | 0.18 | 0.00 |
| Cash | 103.26 | 175.12 | 129.49 | 329.83 |
| Total Equity | 4,527.09 | 3,790.29 | 3,567.36 | 3,387.99 |
| Long Term Investments | 28.50 | 25.24 | 18.58 | 25.10 |
| Retained Earnings( Accumulated Deficit) | 4,450.27 | 3,744.09 | 3,525.82 | 3,352.75 |
| Total Common Shares Outstanding | 12.49 | 12.49 | 12.59 | 12.59 |
| Property/ Plant/ Equipment Total- Gross | 3,212.75 | 2,894.25 | 2,602.02 | 2,460.41 |
| Tangible Book Valueper Share Common Eq | 359.03 | 299.71 | 282.15 | 268.45 |
| Total Liabilities | 1,627.75 | 1,224.66 | 1,071.03 | 1,291.03 |
| Total Debt | 260.17 | 47.42 | 35.28 | 35.63 |
| Short Term Investments | 560.16 | 438.71 | 330.05 | 510.27 |
| Cashand Short Term Investments | 663.42 | 613.83 | 459.54 | 840.10 |
| Total Receivables Net | 2,030.38 | 1,247.05 | 1,356.25 | 1,125.06 |
| Notes Payable/ Short Term Debt | 206.89 | 0.00 | 0.00 | 0.00 |
| Deferred Income Tax | 117.94 | 110.52 | 108.50 | 97.72 |
| Accounts Receivable- Trade Net | 1,862.40 | 1,185.03 | 1,253.38 | 1,059.38 |
| Property/ Plant/ Equipment Total- Net | 2,083.42 | 1,891.77 | 1,720.98 | 1,698.16 |
| Total Current Liabilities | 1,415.75 | 996.10 | 895.25 | 1,139.28 |
| Total Inventory | 1,007.88 | 943.12 | 866.60 | 842.51 |
| ESOP Debt Guarantee | 3.22 | 5.18 | 5.65 | 0.34 |
| Accounts Payable | 544.30 | 454.20 | 463.20 | 422.77 |
| Other Currentliabilities Total | 650.70 | 529.20 | 420.29 | 707.08 |
| Total Long Term Debt | 39.42 | 34.72 | 23.52 | 26.20 |
| Intangibles Net | 41.58 | 46.52 | 14.66 | 7.75 |
| Other Long Term Assets Total | 195.25 | 195.65 | 143.79 | 116.57 |
| Note Receivable- Long Term | 70.66 | 12.74 | 9.46 | 6.26 |
| period Length | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 3,735.43 | 2,843.03 | 2,730.92 | 2,825.18 |
| Capital Lease Obligations | 39.42 | 34.72 | 23.52 | 26.20 |
*All figures in crores except per share values
Ajanta Pharma Quick Links
Ajanta Pharma Dividend Ajanta Pharma Bonus Ajanta Pharma News Ajanta Pharma AGM Ajanta Pharma Rights Ajanta Pharma Splits Ajanta Pharma Board Meetings Ajanta Pharma Key Metrics Ajanta Pharma Shareholdings Ajanta Pharma Profit Loss Ajanta Pharma Cashflow Ajanta Pharma Q1 Results Ajanta Pharma Q2 Results Ajanta Pharma Q3 Results Ajanta Pharma Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
1,199.95+32.15(2.75%)
1,530.00+31.35(2.09%)
3,138.00+54.50(1.77%)
293.10-1.65 (-0.56%)
1,307.70-5.00 (-0.38%)
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.